Osiris Therapeutics ($OSIR) CEO Lode Debrabandere is resigning his position after 10 years at the company, citing "personal reasons." Dwayne Montgomery, Osiris' current chief business officer, is taking over on an interim basis, the company said. Debrabandere has served as CEO since 2013 when his predecessor, Randal Mills, resigned for "personal reasons" of his own. The biotech's shares fell more than 10% on Thursday. More